This is a news story, published by Ars Technica, that relates primarily to Ozempic news.
For more Ozempic news, you can click here:
more Ozempic newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Ars Technica, you can click here:
more news from Ars TechnicaOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
counterfeit weight loss drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest different illegal online pharmacies news, illegal online pharmacies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
generic semaglutide drugsArs Technica
•
76% Informative
Counterfeit drugs sold as equivalents to blockbuster semaglutide drugs Ozempic and Wegovy .
Researchers tested three rogue online pharmacies that didn't require prescriptions.
Three of the pharmacies never delivered the drugs after researchers paid for them.
Compounding pharmacies have stepped in to make copycat versions of the popular drugs.
VR Score
71
Informative language
67
Neutral language
46
Article tone
semi-formal
Language
English
Language complexity
64
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
3
Source diversity
2
Affiliate links
no affiliate links